Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
RP-CARS reveals molecular spatial order anomalies in myelin of an animal model of Krabbe disease.
Relative changes in ankle and hip control during bilateral joint movements in persons with multiple sclerosis.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Mining gene expression data of multiple sclerosis.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
[Treatment of neuromyelitis optica].
Biochemical Pharmacology of the Sigma-1 Receptor.
A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.
Stage-Specific Regulation of Oligodendrocyte Development by Wnt/β-Catenin Signaling.
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Using conceptual work products of case management to design health IT.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Premature immune senescence in children with MS: Too young to go steady.
Rotation-invariant multi-contrast non-local means for MS lesion segmentation.
Outcome measures in multiple sclerosis.
Falls in people with multiple sclerosis compared with falls in healthy controls.
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Defining reliable disability outcomes in multiple sclerosis.
Neurodegeneration: Active astrocytes drive inflammation.
Pages
« first
‹ previous
…
502
503
504
505
506
507
508
509
510
…
next ›
last »